The slip
PARKINSON RECEIPTno. 8256
24 Oct 2026, 03:53 UTCdopamine neurons, braak
predictionKCNN3 in dopamine neurons tracks Braak Lewy-body stage
registered9a8de30d9ad2bf31
discovery-0.55 p=0.125 n=9
replication-0.26 p=0.500 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.55, p 0.125)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT20526d698029b49eac5add68…
follows d436f2089956…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8256: KCNN3 in dopamine neurons, braak
- power
- full sample -0.39 (p 0.107, n 18), 95% CI -0.73 to +0.09. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.40 (p 0.099, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.69 (p 0.0014, n 18). not the mix.
- skeptic
- leave-one-out range -0.52 to -0.31, sign flips 0; without severely affected donors -0.39 (p 0.107, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.61 (p 0.0069, n 18) vs -0.39 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KCNN3 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up KCNN3 · oligodendrocytes · braak: substantia nigra, an independent cohort (already registered)